Scientific
MK5 Microarray Data

Affected Genes - Ontology Breakdown - Gene Enrichment - Proteome Analysis
These are the micro-array results of a differential gene expression microarray experiments and the subsequent analysis steps performed on them. The up/down- regulation ratio was obtained by measuring WT cells against MK5 activated cells. See material and methods for technical information as well as the data usage policy.
MK5 Proteome Analysis

Table 3: Type II network, divided ranks. This table presents the output of the simulation of a type-II network in which we relied on the high confidence interactions and micro-array results. The output of the micro-array was then ranked and these ranks used as input into the network simulation. After performing two such simulations (one for the MK5 off and one for the MK5 on microarray output), we divided the ranks and sorted the results accordingly. The output of this technique is a collection of proteins that cluster naturally together.
Navigation/Query Panel:
Click on the attribute name to hide/unhide it. The green arrows can be used to shift columns left/right. Exact word match is written as =..., regular expressions can be matched with ~.... To select all values larger or equal than use >.... This would be <... for values smaller or equal than. To select all values within a specific range use [...,...].
Rank Gene Hugo Network Comparison Type description Value Type Interaction Map Filtered red green network_comparison
Results: HTML CSV LaTeX
Showing element 1051 to 1100 of 8289 in total
Network Comparison Type: Divided
Value Type: Ranked
Filtered: 1

\def\wcA{0.125\textwidth}
\def\wcB{0.125\textwidth}
\def\wcC{0.125\textwidth}
\def\wcD{0.125\textwidth}
\def\wcE{0.125\textwidth}
\def\wcF{0.125\textwidth}
\def\wcG{0.125\textwidth}
\begin{longtable}{|c|c|c|c|c|c|c|}
\hline
\parbox{\wcA}{\vspace{3pt}\noindent
Rank\vspace{3pt}}&\parbox{\wcB}{\vspace{3pt}\noindent
Hugo\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
description\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Interaction Map\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
red\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
green\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
network\_comparison\vspace{3pt}}\\
\hline
\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
526\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
RRP1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nnp-1 protein (novel nuclear protein 1) (nucleolar protein nop52) (nop52) (d21s2056e). [source:swissprot;acc:p56182]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
250.538\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
234.401\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06884\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC2A9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 9 (glucose transporter type 9). [source:swissprot;acc:q9nrm0]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.549\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.117\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0323\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
527\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX31\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dead (asp-glu-ala-asp) box polypeptide 31 isoform 1; dead/dexh helicase ddx31. [source:refseq;acc:nm\_022779]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
248.56\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
232.579\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06871\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
EIF5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 5 (eif-5). [source:swissprot;acc:p55010]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
208.004\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
201.497\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03229\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
528\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC2A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 2 (glucose transporter type 2, liver). [source:swissprot;acc:p11168]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
205.543\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.115\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03228\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
YME1L1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
yme1-like 1 isoform 3; atp-dependent metalloprotease ftsh1 homolog. [source:refseq;acc:nm\_014263]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.146\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
237.393\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06864\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
529\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DDX18\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
atp-dependent rna helicase ddx18 (dead-box protein 18) (myc-regulated dead-box protein) (mrdb). [source:swissprot;acc:q9nvp1]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
251.653\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
235.506\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06856\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RNF113B\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 183-like 1. [source:refseq;acc:nm\_178861]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.116\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
198.702\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.03228\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
530\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 3 (glucose transporter type 3, brain). [source:swissprot;acc:p11169]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
205.541\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.114\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
LSM6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
u6 snrna-associated sm-like protein lsm6 (sm protein f). [source:swissprot;acc:q9y4y8]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
227.483\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
212.994\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06803\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
531\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
PRPF19\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
nuclear matrix protein nmp200 related to splicing factor prp19. [source:refseq;acc:nm\_014502]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
223.356\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
209.149\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06793\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC2A4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 4 (glucose transporter type 4, insulin-responsive). [source:swissprot;acc:p14672]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.54\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.114\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.03227\vspace{3pt}}}\\\cline{1-3}\cline{5-6}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
532\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC2A14\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
glucose transporter 14. [source:refseq;acc:nm\_153449]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
205.541\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.115\vspace{3pt}}&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZNF622\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger-like protein 9. [source:refseq;acc:nm\_033414]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
250.942\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
235.004\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06782\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
533\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
SLC2A1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
solute carrier family 2, facilitated glucose transporter, member 1 (glucose transporter type 1, erythrocyte/brain) (hepg2 glucose transporter). [source:swissprot;acc:p11166]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
205.533\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
199.112\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03225\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SLC45A2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
membrane-associated transporter protein (aim-1 protein) (melanoma antigen aim1). [source:swissprot;acc:q9umx9]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
250.942\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
235.004\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.06782\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
534\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
guanine nucleotide-binding protein-like 1 (gtp-binding protein hsr1). [source:swissprot;acc:p36915]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZFAND5\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
zinc finger protein 216. [source:swissprot;acc:o76080]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
184.361\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
178.613\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03218\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
535\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2H\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerases i, ii, and iii 17.1 kda polypeptide (ec 2.7.7.6) (rpb17) (rpb8) (rpabc3). [source:swissprot;acc:p52434]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.662\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
252.708\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0678\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
ZFAND6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein associated with prk1. [source:refseq;acc:nm\_019006]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
184.361\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
178.613\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03218\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
536\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
RANBP9\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
ran binding protein 9; novel centrosomal protein ranbpm; ran binding protein, centrosomal. [source:refseq;acc:nm\_005493]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
203.519\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.195\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03207\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SSB\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
lupus la protein (sjogren syndrome type b antigen) (ss-b) (la ribonucleoprotein) (la autoantigen). [source:swissprot;acc:p05455]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
242.531\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
227.136\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06778\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
537\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
DHX15\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
putative pre-mrna splicing factor rna helicase (deah box protein 15) (atp-dependent rna helicase #46). [source:swissprot;acc:o43143]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
229.803\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
215.301\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06736\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF11\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf11 protein. [source:refseq;acc:nm\_032445]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.951\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
201.517\vspace{3pt}}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03193\vspace{3pt}}\\\cline{1-3}\cline{5-5}\cline{7-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
538\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
MEGF10\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
megf10 protein. [source:refseq;acc:nm\_032446]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
207.949\vspace{3pt}}&&\parbox{\wcG}{\vspace{3pt}\noindent
1.03192\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
POLR2L\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
dna-directed rna polymerase ii 7.6 kda polypeptide (ec 2.7.7.6) (rpb10) (rpb7.6) (rpabc5). [source:swissprot;acc:p52436]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
237.627\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
253.604\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06724\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
539\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CRBN\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein x 0001. [source:refseq;acc:nm\_016302]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
199.661\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
193.489\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.0319\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
MEMO1P\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
protein cgi-27 (c21orf19-like protein). [source:swissprot;acc:q9y316]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
236.964\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
252.86\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06708\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
540\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
SEPHS2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
selenide,water dikinase 2 (ec 2.7.9.3) (selenophosphate synthetase 2) (selenium donor protein 2). [source:swissprot;acc:q99611]\vspace{3pt}}}&&\parbox{\wcE}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{4-7}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.027\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03189\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
541\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
MICAL2\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
flavoprotein oxidoreductase mical2. [source:refseq;acc:nm\_014632]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{4-7}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.027\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03189\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
542\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
INPP4B\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type ii, 105kd; inositol polyphosphate 4-phosphatase ii; 4-phosphatase ii. [source:refseq;acc:nm\_003866]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{4-7}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.027\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03189\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
543\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
SEPHS1\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
selenide,water dikinase 1 (ec 2.7.9.3) (selenophosphate synthetase 1) (selenium donor protein 1). [source:swissprot;acc:p49903]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{4-7}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.027\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03189\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
544\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcB}{\vspace{3pt}\noindent
INPP4A\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcC}{\vspace{3pt}\noindent
inositol polyphosphate-4-phosphatase, type 1 isoform b; inositol polyphosphate-4-phosphatase, type i, 107kd; 4-phosphatase i; inositol polyphosphate-4-phosphatase i. [source:refseq;acc:nm\_001566]\vspace{3pt}}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
222.156\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
208.201\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06703\vspace{3pt}}\\\cline{4-7}
&&&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
206.406\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
200.027\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03189\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
545\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
EIF6\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
eukaryotic translation initiation factor 6 (eif-6) (b4 integrin interactor) (cab) (p27(bbp)) (b(2)gcn homolog). [source:swissprot;acc:p56537]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
248.866\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
233.287\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06678\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
RPUSD2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
c18b11 homolog (44.9kd). [source:refseq;acc:nm\_152260]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcE}{\vspace{3pt}\noindent
202.949\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcF}{\vspace{3pt}\noindent
196.678\vspace{3pt}}}&\multirow{2}{*}{\parbox{\wcG}{\vspace{3pt}\noindent
1.03188\vspace{3pt}}}\\\cline{1-3}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
546\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
TMBIM4\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
z-protein (protein cgi-119) (s1r protein). [source:swissprot;acc:q9hc24]\vspace{3pt}}&&&&\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
WAS\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
wiskott-aldrich syndrome protein (wasp). [source:swissprot;acc:p42768]\vspace{3pt}}&\multirow{2}{*}{\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.222\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.262\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06671\vspace{3pt}}\\\cline{1-3}\cline{5-7}
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
547\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
CRK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proto-oncogene c-crk (p38) (adapter molecule crk). [source:swissprot;acc:p46108]\vspace{3pt}}&&\parbox{\wcE}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN3\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 3. [source:swissprot;acc:p58005]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.305\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.023\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03188\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
548\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
ABL2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosine-protein kinase abl2 (ec 2.7.1.112) (tyrosine kinase arg). [source:swissprot;acc:p42684]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
FLOT1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
flotillin-1. [source:swissprot;acc:o75955]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.303\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.022\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03188\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
549\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
proto-oncogene tyrosine-protein kinase src (ec 2.7.1.112) (p60-src) (c-src). [source:swissprot;acc:p12931]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN2\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 2 (hi95). [source:swissprot;acc:p58004]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.306\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.024\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03188\vspace{3pt}}\\\hline
\multirow{2}{*}{\parbox{\wcA}{\vspace{3pt}\noindent
550\vspace{3pt}}}&\parbox{\wcB}{\vspace{3pt}\noindent
HCK\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
tyrosine-protein kinase hck (ec 2.7.1.112) (p59-hck/p60-hck) (hemopoietic cell kinase). [source:swissprot;acc:p08631]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
High confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
207.26\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
194.346\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.06645\vspace{3pt}}\\\cline{2-7}
&\parbox{\wcB}{\vspace{3pt}\noindent
SESN1\vspace{3pt}}&\parbox{\wcC}{\vspace{3pt}\noindent
sestrin 1 (p53-regulated protein pa26). [source:swissprot;acc:q9y6p5]\vspace{3pt}}&\parbox{\wcD}{\vspace{3pt}\noindent
Low confidence\vspace{3pt}}&\parbox{\wcE}{\vspace{3pt}\noindent
203.299\vspace{3pt}}&\parbox{\wcF}{\vspace{3pt}\noindent
197.018\vspace{3pt}}&\parbox{\wcG}{\vspace{3pt}\noindent
1.03188\vspace{3pt}}\\\hline
nd{longtable}

Legend:
- Rank is the rank after comparing the two networks

 - Gene is the ensembl human gene identifier measured by 1 or more probes on the microarray

 - Hugo is the HGNC identifier if it exists

 - Value Type describes how the microarray measurement was processed. Ranked indicates that we sorted all measurements and use the rank as red and green value. Measured is the normal measurement. Squared and Rooted are the square and square root respecitcely. This might be valueable to compensate for non linear light distributions.

 - Network Comparison Type describes whether we divided the red and green types or whether we sutractcted them

 - Interaction Map specifies whether we used only the hig hconfidence protein-protein interactions or also included the low confidence interactions.

 - Filtered specifies whether we only included the high confidence microarry measurements or not.
- http://analysis.yellowcouch.org/